| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
540,054 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,092,104 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
787,587 |
|
|
| Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -13.1%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 35
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-12 |
4/A |
AB |
$7.00 |
$3,500 |
D/D |
500 |
7,000 |
2.73 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-08-02 |
4 |
S |
$84.73 |
$31,943 |
D/D |
(377) |
7,055 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-03-29 |
4 |
A |
$86.01 |
$14,450 |
D/D |
168 |
7,064 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-10-31 |
4 |
AB |
$6.92 |
$3,584 |
D/D |
518 |
7,213 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-12-17 |
4 |
AS |
$35.15 |
$532,934 |
D/D |
(15,000) |
7,213 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-01-02 |
4 |
AS |
$35.28 |
$540,978 |
D/D |
(15,000) |
7,213 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-03-04 |
4 |
S |
$38.00 |
$152,000 |
D/D |
(4,000) |
7,213 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-09-30 |
4 |
A |
$74.23 |
$16,256 |
D/D |
219 |
7,274 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-08-01 |
4 |
S |
$85.16 |
$114,711 |
D/D |
(1,347) |
7,432 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-12-31 |
4 |
A |
$87.32 |
$16,591 |
D/D |
190 |
7,464 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-09-28 |
4 |
AS |
$25.00 |
$480,175 |
D/D |
(19,207) |
7,488 |
0 |
- |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2023-11-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,615 |
|
% |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-03-31 |
4 |
A |
$73.23 |
$17,282 |
D/D |
236 |
7,700 |
0 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • – |
2001-04-23 |
4 |
B |
$12.00 |
$99,996 |
D/D |
8,333 |
8,333 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-11-01 |
4 |
AB |
$8.36 |
$12,550 |
D/D |
1,500 |
8,500 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-05-02 |
4 |
AS |
$36.50 |
$376,050 |
D/D |
(10,100) |
8,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-05-09 |
4 |
S |
$38.39 |
$310,031 |
D/D |
(8,000) |
8,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-05-15 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
8,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
8,567 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,520 |
8,584 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-11-10 |
4 |
S |
$83.00 |
$66,234 |
D/D |
(798) |
8,646 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2007-07-05 |
4 |
AS |
$18.21 |
$36,582 |
D/D |
(2,000) |
8,695 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2019-06-28 |
4 |
A |
$84.96 |
$16,567 |
D/D |
195 |
8,779 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-12-31 |
4 |
A |
$86.98 |
$23,920 |
D/D |
275 |
8,921 |
0 |
- |
|
| INCY |
Incyte Corp |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,282 |
8,982 |
0 |
- |
|
853 Records found
|
|
Page 3 of 35 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
